Alerts will be sent to your verified email
Verify Email
ANUHPHR
|
Anuh Pharma
|
Wanbury
|
Sakar Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
R&D as a % of Total Sales
|
0.0 | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
15.87 % | -11.27 % | 9.28 % |
|
5yr average Equity Multiplier
|
1.62 | -1.35 | 1.75 |
|
5yr Average Asset Turnover Ratio
|
1.35 | 1.54 | 0.5 |
|
5yr Avg Net Profit Margin
|
7.23 % | 5.09 % | 10.38 % |
|
Price to Book
|
2.51 | 13.78 | 2.84 |
|
P/E
|
17.71 | 19.02 | 41.08 |
|
5yr Avg Cash Conversion Cycle
|
42.81 Days | -103.0 Days | -14.29 Days |
|
Inventory Days
|
50.87 Days | 21.96 Days | 46.75 Days |
|
Days Receivable
|
111.12 Days | 61.39 Days | 51.16 Days |
|
Days Payable
|
117.6 Days | 194.51 Days | 103.34 Days |
|
5yr Average Interest Coverage Ratio
|
48.66 | 2.13 | 5.43 |
|
5yr Avg ROCE
|
21.17 % | -37.9 % | 10.08 % |
|
5yr Avg Operating Profit Margin
|
10.21 % | 7.72 % | 24.06 % |
|
5 yr average Debt to Equity
|
0.02 | 0.2 | 0.47 |
|
5yr CAGR Net Profit
|
10.73 % | n/a | 3.94 % |
|
5yr Average Return on Assets
|
9.84 % | 7.92 % | 5.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.92 % | 39.63 % | 52.86 % |
|
Share Pledged by Promoters
|
0.0 | 76.74 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.67 % | -0.22 % | -14.68 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Anuh Pharma
|
Wanbury
|
Sakar Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|